secwatch / observer
8-K filed September 10, 2025, 7:59 PM ET ticker NIXX CIK 0001462223
debt confidence high sentiment neutral materiality 0.65

Nixxy, Inc. (NIXX): debt financing — Nixxy enters $2M convertible credit line with Siwatex OÜ at 8.25%, $2.00 floor conversion price

Nixxy, Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Nixxy, Inc. incurred revolving credit of up to $2,000,000 with Siwatex OÜ at 8.25% maturing twelve (12) months from the Effective Date.

Instrument
revolving credit
Principal
up to $2,000,000
Counterparty
Siwatex OÜ
Rate
8.25%
Maturity
twelve (12) months from the Effective Date
Event
incurrence
Exact text from the filing
On September 4, 2025, Nixxy Inc. (the “Company”) entered into a Convertible Line of Credit Agreement (the “Agreement”) with Siwatex OÜ, a limited liability company incorporated in Estonia (the “Lender”), effective on September 2, 2025 (the “Effective Date”). Under the Agreement, the Lender has agreed to make available to the Company a convertible revolving line of credit in the principal amount of up to $2,000,000, that may be used to working capital and general corporate purposes of the Company and its subsidiaries (the “Credit Line”).
View on SEC.gov
Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.4

Nixxy, Inc. issued convertible note to Siwatex OÜ for up to $2,000,000.

Security
convertible note
Purchaser
Siwatex OÜ
Consideration
up to $2,000,000
Exact text from the filing
the Lender has agreed to make available to the Company a convertible revolving line of credit in the principal amount of up to $2,000,000
View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

Nixxy, Inc. filing history →

Source: SEC EDGAR
accession 0001683168-25-006827
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.